儿童糖尿病管理市场－全球产业规模、份额、趋势、机会和预测（按产品、技术、最终用户、地区和竞争细分，2020-2030 年）

2024 年全球儿童糖尿病管理市场价值为 56.6 亿美元，预计到 2030 年将达到 100.1 亿美元，复合年增长率为 9.94%。由于儿童和青少年的糖尿病盛行率不断上升，全球儿童糖尿病管理市场正在经历显着增长，这推动了对创新管理解决方案的需求。儿童糖尿病，尤其是第 1 型糖尿病，需要持续监测和精确的胰岛素注射，以预防糖尿病酮症酸中毒等急性併发症以及对生长发育的长期影响。持续血糖监测 (CGM) 系统、自动胰岛素输送 (AID) 设备和智慧胰岛素帮浦等技术的进步，使得血糖水平管理更加精确和便捷。医院、诊所和家庭护理机构越来越多地将这些解决方案整合到护理方案中，以提高患者的依从性和临床结果。父母、照顾者和医疗保健提供者对早期介入和有效糖尿病管理重要性的认识不断提高，这也促进了市场的扩张。

市场受到多种关键因素的驱动。全球儿童糖尿病发生率的上升导致患者群体不断扩大，需要持续监测和个人化照护。采用先进的胰岛素输送系统和连续血糖监测 (CGM) 设备可以更好地控制血糖，降低急性紧急情况和长期併发症的风险。医疗保健提供者正在强调以患者为中心的方法，根据儿童个别需求制定治疗方案，并利用数位工具追踪血糖水平、调整胰岛素剂量并提供远端监控。医疗技术的不断进步，包括预测分析和数据驱动的决策，使临床医生能够预测高风险事件并主动干预。医疗器材公司不断增加研发投入，正在加速儿童糖尿病管理解决方案的创新，为病患和医疗保健专业人员提供更安全、更有效率、更便利的选择。

市场新兴趋势包括互联医疗技术的整合，该技术将连续血糖监测 (CGM)资料与胰岛素输送系统相结合，以实现即时调整。远距医疗平台支援远端监控和咨询，帮助家庭在家中管理儿童糖尿病，同时减少就诊次数。个人化治疗方法，包括演算法驱动的胰岛素给药，正在提高护理的精确度和有效性。儘管成长前景强劲，但市场仍面临诸多挑战，例如某些地区的认知度有限、先进设备成本高昂（可能限制其普及性），以及需要对医疗保健专业人员进行专业培训以有效使用这些技术。监管障碍以及对新设备长期安全性和有效性的担忧可能会减缓其采用。透过教育、政策支援和技术创新来应对这些挑战，对于维持全球儿童糖尿病管理市场的成长至关重要，从而确保糖尿病儿童获得更好的治疗结果。

关键市场驱动因素

儿童糖尿病盛行率上升

主要市场挑战

先进设备和疗法的成本高昂

主要市场趋势

数位健康解决方案整合

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球儿童糖尿病管理市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 副产物（血糖监测仪 (BGM)、连续血糖监测仪 (CGM)、胰岛素帮浦、胰岛素笔、胰岛素注射器）
  • 按技术（连网设备、非连网设备）
  • 按最终使用者（医院、家庭护理、儿科诊所）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美儿童糖尿病管理市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲儿童糖尿病管理市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区儿童糖尿病管理市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲儿童糖尿病管理市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲儿童糖尿病管理市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第十三章：干扰：衝突、流行病与贸易壁垒

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Medtronic plc
• DexCom, Inc.
• Abbott Laboratories
• Tandem Diabetes Care, Inc.
• Insulet Corporation
• Novo Nordisk A/S
• Sanofi SA
• Eli Lilly and Company
• Roche Diabetes Care, Inc.
• Ascensia Diabetes Care Holdings AG

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Pediatric Diabetes Management Market was valued at USD 5.66 Billion in 2024 and is expected to reach USD 10.01 Billion by 2030 with a CAGR of 9.94%. The Global Pediatric Diabetes Management Market is witnessing significant growth due to the increasing prevalence of diabetes among children and adolescents, which is driving demand for innovative management solutions. Pediatric diabetes, particularly type 1 diabetes, requires continuous monitoring and precise insulin administration to prevent acute complications such as diabetic ketoacidosis and long-term effects on growth and development. Advances in technology, including continuous glucose monitoring (CGM) systems, automated insulin delivery (AID) devices, and smart insulin pumps, are enabling more precise and convenient management of blood glucose levels. Hospitals, clinics, and homecare settings are increasingly integrating these solutions into care protocols, improving patient adherence and clinical outcomes. Growing awareness among parents, caregivers, and healthcare providers regarding the importance of early intervention and effective diabetes management is also contributing to the market's expansion.

The market is being driven by several key factors. Rising incidence of pediatric diabetes globally is creating a larger patient pool that requires continuous monitoring and personalized care. Adoption of advanced insulin delivery systems and CGM devices enables better glycemic control, reducing the risk of acute emergencies and long-term complications. Healthcare providers are emphasizing patient-centric approaches, tailoring treatment plans to individual children's needs, and leveraging digital tools to track glucose levels, adjust insulin dosing, and provide remote monitoring. Continuous advancements in medical technologies, including predictive analytics and data-driven decision-making, allow clinicians to anticipate high-risk episodes and intervene proactively. Increasing investments in research and development by medical device companies are accelerating innovation in pediatric diabetes management solutions, offering safer, more efficient, and user-friendly options for both patients and healthcare professionals.

Emerging trends in the market include the integration of connected healthcare technologies that combine CGM data with insulin delivery systems for real-time adjustments. Telemedicine platforms are supporting remote monitoring and consultation, helping families manage pediatric diabetes at home while reducing hospital visits. Personalized treatment approaches, including algorithm-driven insulin dosing, are enhancing the precision and effectiveness of care. Despite strong growth prospects, the market faces challenges such as limited awareness in certain regions, high costs of advanced devices that may restrict accessibility, and the need for specialized training of healthcare professionals to use these technologies effectively. Regulatory hurdles and concerns regarding long-term safety and efficacy of new devices may slow adoption. Addressing these challenges through education, policy support, and technological innovation is essential to sustaining growth in the Global Pediatric Diabetes Management Market, ensuring better outcomes for children living with diabetes.

Key Market Drivers

Rising Prevalence of Pediatric Diabetes

A major driver of the Global Pediatric Diabetes Management Market is the rising prevalence of pediatric diabetes, which has been increasing steadily due to a combination of genetic, environmental, and lifestyle factors. Type 1 diabetes remains the most common form among children and adolescents, requiring lifelong insulin therapy and continuous monitoring to prevent acute complications such as diabetic ketoacidosis (DKA) and long-term health issues affecting growth, cardiovascular health, and kidney function. At the same time, the incidence of type 2 diabetes is rising among younger populations, driven by childhood obesity, sedentary lifestyles, and poor dietary habits, creating an additional patient pool that requires regular monitoring, insulin therapy, and lifestyle interventions. According to the International Diabetes Federation, around 1.52 million people aged 20 years had diabetes in 2022, highlighting the significant burden of the disease and underscoring the urgent need for effective management solutions. This dual burden of type 1 and type 2 diabetes is intensifying demand for reliable pediatric diabetes management products and services.

Healthcare providers are recognizing the critical need for early diagnosis and intervention to manage glycemic levels efficiently and prevent complications. Continuous glucose monitoring (CGM) systems, automated insulin delivery (AID) devices, and smart insulin pumps are increasingly being adopted to provide real-time insights, personalized insulin dosing, and predictive alerts for hypoglycemic or hyperglycemic events. Rising prevalence is also driving investment in caregiver education programs and pediatric-specific treatment protocols, ensuring adherence to therapy and effective disease management. The increasing number of children diagnosed with diabetes is prompting healthcare systems, hospitals, and clinics to expand infrastructure, implement advanced monitoring solutions, and integrate digital health tools to improve patient outcomes. This growing patient base, combined with technological advancements and awareness initiatives, is a key factor propelling the expansion of the pediatric diabetes management market globally, reflecting the urgent need for specialized and accessible care solutions for young patients living with diabetes.

Key Market Challenges

High Cost of Advanced Devices and Therapies

A significant challenge facing the Global Pediatric Diabetes Management Market is the high cost of advanced devices and therapies, which limits accessibility for many families, particularly in low- and middle-income regions. Advanced technologies such as continuous glucose monitors (CGM), automated insulin delivery (AID) systems, and smart insulin pumps offer precision, convenience, and improved glycemic control, but their high purchase prices often ranging from USD 1,000-6,000 for pumps and USD 2,000-5,000 annually for CGM sensors create substantial financial barriers. Many families are unable to afford these technologies without adequate insurance coverage or government subsidies, resulting in disparities in pediatric diabetes care. The cost factor affects device adoption and long-term treatment adherence, as children relying on traditional finger-prick glucose meters and manual insulin injections face less precise monitoring, increasing the risk of acute complications such as diabetic ketoacidosis (DKA) and long-term health consequences.

High costs also constrain healthcare providers in standardizing advanced management solutions, especially in emerging markets with limited healthcare budgets. Manufacturers face the challenge of balancing innovation with affordability, as pediatric-specific R&D investments are substantial. To mitigate these barriers, strategies such as developing lower-cost alternatives, expanding insurance coverage, offering patient assistance programs, and implementing government subsidies are critical. Without such measures, the high expense of advanced devices and therapies will continue to impede adoption and limit the overall growth potential of the Global Pediatric Diabetes Management Market.

Key Market Trends

Integration of Digital Health Solutions

The integration of digital health solutions is a transformative trend in the Global Pediatric Diabetes Management Market, significantly enhancing the monitoring and management of pediatric diabetes. Digital health technologies, including mobile applications, cloud-based platforms, and telemedicine tools, allow caregivers and healthcare providers to access real-time data on blood glucose levels, insulin administration, and lifestyle factors. Continuous glucose monitoring (CGM) systems integrated with these platforms provide automated alerts for hypo- or hyperglycemic events, enabling timely interventions and reducing the risk of complications such as diabetic ketoacidosis. Integration of digital platforms with insulin pumps and automated insulin delivery (AID) systems further enhances personalized care by enabling real-time adjustments to insulin dosing based on predictive algorithms and trend analysis.

Remote monitoring capabilities offered by digital solutions allow healthcare professionals to supervise pediatric patients outside hospital settings, improving adherence and reducing the frequency of emergency visits or hospitalizations. These platforms also facilitate better communication between caregivers, patients, and clinicians, ensuring coordinated care and informed decision-making. Data collected through digital health systems can be analyzed to identify patterns in glucose fluctuations, evaluate the effectiveness of treatment protocols, and optimize long-term management strategies. Growing investment in healthcare IT infrastructure, increasing smartphone penetration, and rising awareness among parents and healthcare providers about the benefits of connected care are accelerating adoption of digital solutions. Integration of wearable sensors, artificial intelligence, and predictive analytics is enhancing the precision and efficiency of diabetes management, providing actionable insights and supporting proactive interventions. This convergence of technology and healthcare is shaping a patient-centric, data-driven approach, driving innovation and improving outcomes in pediatric diabetes management across diverse healthcare settings.

Key Market Players

• Medtronic plc
• DexCom, Inc.
• Abbott Laboratories
• Tandem Diabetes Care, Inc.
• Insulet Corporation
• Novo Nordisk A/S
• Sanofi S.A.
• Eli Lilly and Company
• Roche Diabetes Care, Inc.
• Ascensia Diabetes Care Holdings AG

Report Scope:

In this report, the Global Pediatric Diabetes Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pediatric Diabetes Management Market, By Product:

• Blood Glucose Monitors (BGM)
• Continuous Glucose Monitors (CGM)
• Insulin Pumps
• Insulin Pens
• Insulin Syringes

Pediatric Diabetes Management Market, By Technology:

• Connected Devices
• Non-connected Devices

Pediatric Diabetes Management Market, By End User:

• Hospitals
• Homecare
• Pediatric Clinics

Pediatric Diabetes Management Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pediatric Diabetes Management Market.

Available Customizations:

Global Pediatric Diabetes Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Pediatric Diabetes Management Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Blood Glucose Monitors (BGM), Continuous Glucose Monitors (CGM), Insulin Pumps, Insulin Pens, Insulin Syringes)
  • 5.2.2. By Technology (Connected Devices, Non-connected Devices)
  • 5.2.3. By End User (Hospitals, Homecare, Pediatric Clinics)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Pediatric Diabetes Management Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pediatric Diabetes Management Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By End User
  • 6.3.2. Mexico Pediatric Diabetes Management Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By End User
  • 6.3.3. Canada Pediatric Diabetes Management Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By End User

7. Europe Pediatric Diabetes Management Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Pediatric Diabetes Management Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Pediatric Diabetes Management Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Pediatric Diabetes Management Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Pediatric Diabetes Management Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Pediatric Diabetes Management Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By End User

8. Asia-Pacific Pediatric Diabetes Management Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pediatric Diabetes Management Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By End User
  • 8.3.2. India Pediatric Diabetes Management Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By End User
  • 8.3.3. South Korea Pediatric Diabetes Management Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By End User
  • 8.3.4. Japan Pediatric Diabetes Management Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Pediatric Diabetes Management Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By End User

9. South America Pediatric Diabetes Management Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pediatric Diabetes Management Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Pediatric Diabetes Management Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Pediatric Diabetes Management Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By End User

10. Middle East and Africa Pediatric Diabetes Management Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pediatric Diabetes Management Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Pediatric Diabetes Management Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Pediatric Diabetes Management Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic plc
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. DexCom, Inc.
• 15.3. Abbott Laboratories
• 15.4. Tandem Diabetes Care, Inc.
• 15.5. Insulet Corporation
• 15.6. Novo Nordisk A/S
• 15.7. Sanofi S.A.
• 15.8. Eli Lilly and Company
• 15.9. Roche Diabetes Care, Inc.
• 15.10. Ascensia Diabetes Care Holdings AG

16. Strategic Recommendations

17. About Us & Disclaimer